Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
Q4
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for NEUROCRINE BIOSCIENCES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $70,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q4
LMH STRATEGIC SOLUTIONS for HARMONY BIOSCIENCES
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q4
LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for EXELIXIS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q4
LMH STRATEGIC SOLUTIONS for BIOMARIN PHARMACEUTICAL, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS, PLC
4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000.00 income
Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for ARDELYX, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q4
LMH STRATEGIC SOLUTIONS for ACADIA PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
SURESCRIPTS for SURESCRIPTS
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Health Issues, Pharmacy
View →
Q4
AMERICAN VETERINARY MEDICAL ASSOCIATION for AMERICAN VETERINARY MEDICAL ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Agriculture, Animals, Budget/Appropriations, Pharmacy
View →
Q4
PANNONE LOPES DEVEREAUX & O'GARA LLC for AMGEN
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · $9,000.00 income
Pharmacy
View →
Q4
MR. H.R. BERT PENA for MARGO RX LLC(DBA RICHARD'S PHARMACY)
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate
Pharmacy
View →
Q4
NAVITUS HEALTH SOLUTIONS for NAVITUS HEALTH SOLUTIONS
4th Quarter (Oct 1 - Dec 31) 2025 · Wisconsin · House · Senate
Health Issues, Insurance, Pharmacy, Labor Issues/Antitrust/Workplace
View →
Q4
VENABLE LLP for MEDISCA INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New York · $20,000.00 income
Pharmacy
View →
Q1
BGR GOVERNMENT AFFAIRS for WALGREEN CO.
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate
Pharmacy
View →
Q4
BGR GOVERNMENT AFFAIRS for WALGREEN CO.
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $50,000.00 income
Pharmacy
View →
Q4
BGR GOVERNMENT AFFAIRS for WALGREEN CO.
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $50,000.00 income
Pharmacy
View →
Q1
BGR GOVERNMENT AFFAIRS for NEUROCRINE BIOSCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate
Pharmacy
View →
Q4
BGR GOVERNMENT AFFAIRS for NEUROCRINE BIOSCIENCES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Pharmacy
View →
Q4
AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q4
AEGIS LLC for TRIS PHARMA, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 income
Pharmacy
View →
RR
LMH STRATEGIC SOLUTIONS for SAVARA INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania
Pharmacy, Medicare/Medicaid
View →
Q4
TRUSYNERGY for BURRELL INTERNATIONAL GROUP LLC (ON BEHALF OF SHIONOGI INC.)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $10,000.00 income
Pharmacy
View →
Previous Page 29 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem